GlassScriptPhysician profile
Kevin A Barber
NPI 1013303700
$3,624.30
in general payments reported to CMS, 2019-2025
28 companies · $617 in 2025
The $617 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79.85 · 2020: $381 · 2021: $907 · 2022: $728 · 2023: $349 · 2024: $563 · 2025: $617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,529.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,528.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $560.95 | 2019-2023 | Lo Loestrin Fe |
| Pfizer INC. | $385.84 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $310.88 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $224.93 | 2023-2025 | Myfembree |
| Biogen, INC. | $219.82 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $213.15 | 2022-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $208.38 | 2020-2025 | |
| Organon LLC | $200.88 | 2021-2025 | Nexplanon, Jada System |
| Myovant Sciences INC. | $182.10 | 2021-2022 | |
| Avion Pharmaceuticals | $177.82 | 2020-2022 | |
| Hologic Sales and Service, LLC | $149.85 | 2021-2025 | Aptima, Thinprep 2000 Processor, Coolseal Generator |
| Therapeuticsmd, INC. | $133.20 | 2019-2022 | |
| Aspira Women'S Health INC | $131.15 | 2021 | |
| Evofem Biosciences, INC. | $119.80 | 2021-2022 | |
| Shield Therapeutics INC | $79.13 | 2023-2024 | Accrufer |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $56.84 | 2021-2022 | |
| Dexcom, INC. | $39.96 | 2024-2025 | Dexcom G6 Transmitter |
| Exeltis, USA INC. | $35.44 | 2025 | Slynd |
| Mylan Pharmaceuticals INC. | $33.17 | 2021-2022 | |
| Minerva Surgical, INC | $28.00 | 2021-2022 | |
| Ethicon US, LLC | $22.20 | 2020 | |
| Innovation Technologies INC | $21.64 | 2025 | Irrisept |
| Solventum Corporation | $18.26 | 2024 | Prevena |
| Radius Health, INC. | $17.66 | 2020 | |
| Coloplast Corp | $14.57 | 2022 | |
| Duchesnay USA Incorporated | $13.87 | 2019 | |
| Merck Sharp & Dohme LLC | $12.49 | 2019 | |
| Amag Pharmaceuticals, INC. | $12.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Barber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.